Ten years later, 3APs were studied as inhibitors of GSK-3β, a serine/threonine kinase that plays critical roles in multiple cellular functions in the central nervous system and is considered a key player in Alzheimer’s disease (AD) pathophysiology. This evidence concerns the gene MARK2 and Alzheimer disease.